Professor Vijay Kunadian

Prof Kunadian is UK's first female Professor of Interventional Cardiology based at Newcastle University and Freeman Hospital, Newcastle upon Tyne, UK. She has championed diversity in her specialty as a role model; only 5% of interventional cardiologist are female in the UK, <1% are clinical academics. She is UK Chief Investigator in many clinical trials (BHF SENIOR RITA Trial, TWILIGHT trial, XIENCE SHORT DAPT Trial, PACIFIC AMI Trial, AEGIS2 Trial, ICON1 study, ASPIRE study, APPLE COPD Trial) with major grant awards including from the British Heart Foundation and >250 peer reviewed publications in major journals such as New England Journal of Medicine, Lancet, European Heart Journal, Circulation, Journal of the American College of Cardiology, Heart BMJ. Her research leadership roles include Country Lead, Trial Executive Steering Committee Member in TWILIGHT, Xience Short DAPT, AEGIS 2, PACIFIC AMI, iCORMICA trials (TSC Chair), ARTEMIS, COMPLETE-2, MariTide ASCVD;